Correction to α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParkinson's Disease Mechanisms and Treatments · Nuclear Receptors and Signaling
Annals of Clinical and Translational Neurology 2016; 3(8): 588–606. doi: 10.1002/acn3.321
The authors regret that an error occurred during the assembly of Fig. 1A and C where the incorrect panel was used to represent the non‐tg Pen‐D5 and the α‐syn tg control condition. The corrected figure is provided in the attachment. We apologize for this error.